TNF and metabolic dysfunction-associated steatotic liver disease: Tumor necrosis factor-α (TNF-α) is increased in NAFLD patients and TNF-α inhibition, obtained by administration of pentoxifylline, was shown to reduce hepatocyte inflammation together with normalization of liver function [139].